Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations.
Propensity-score matching is increasingly being used to reduce the impact of treatment-selection bias when estimating causal treatment effects using observational data. Several propensity-score matching methods are currently employed in the medical literature: matching on the logit of the propensity score using calipers of width either 0.2 or 0.6 of the standard deviation of the logit of the propensity score; matching on the propensity score using calipers of 0.005, 0.01, 0.02, 0.03, and 0.1; and 5 --> 1 digit matching on the propensity score. We conducted empirical investigations and Monte Carlo simulations to investigate the relative performance of these competing methods. Using a large sample of patients hospitalized with a heart attack and with exposure being receipt of a statin prescription at hospital discharge, we found that the 8 different methods produced propensity-score matched samples in which qualitatively equivalent balance in measured baseline variables was achieved between treated and untreated subjects. Seven of the 8 propensity-score matched samples resulted in qualitatively similar estimates of the reduction in mortality due to statin exposure. 5 --> 1 digit matching resulted in a qualitatively different estimate of relative risk reduction compared to the other 7 methods. Using Monte Carlo simulations, we found that matching using calipers of width of 0.2 of the standard deviation of the logit of the propensity score and the use of calipers of width 0.02 and 0.03 tended to have superior performance for estimating treatment effects.
Austin
Peter C
PC
Institute for Clinical Evaluative Sciences, Toronto, ON, Canada. peter.austin@ices.on.ca
D000465:Algorithms; D015982:Bias; D001699:Biometry / Q000379:methods; D002170:Canada / Q000453:epidemiology; D015986:Confounding Factors, Epidemiologic; D003627:Data Interpretation, Statistical; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015994:Incidence; D009010:Monte Carlo Method; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality*; D055656:Prescriptions / Q000706:statistics & numerical data*; D016016:Proportional Hazards Models; D016019:Survival Analysis; D015996:Survival Rate
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors